{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:41:42Z","timestamp":1791632502425,"version":"4.3.4"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Helicobacter pylori<\/jats:italic> infection is still frequent in the community and all infected subjects should be offered an eradication therapy. Nowadays physicians have to face the challenge of antibiotic resistance in treating <jats:italic>Helicobacter pylori<\/jats:italic>\u2010infected individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>This review provides an overview of current international guidelines and reports recent evidence from systematic reviews and clinical trials on the treatment of <jats:italic>Helicobacter pylori<\/jats:italic> infection and should help physicians to better treat their patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>General rules to optimize the management of <jats:italic>Helicobacter pylori<\/jats:italic> infection include: (i) considering previous patient's exposure to antibiotics; (ii) using high dose of proton\u2010pump inhibitors; and (iii) avoiding repeating the same regimen, if it has already failure. Bismuth quadruple therapy and concomitant therapy are the best first\u2010line empirical treatments in areas with high clarithromycin resistance and in individuals with previous use of macrolides; otherwise, the 14\u2010day clarithromycin\u2010containing triple therapy is a valid regimen. The sequential therapy is no longer a suggested treatment by international guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Current international guidelines are consistent in defining treatment strategies for <jats:italic>Helicobacter pylori<\/jats:italic> infection. The use of national registries to monitor the efficacy and tolerability of different regimens in the real world of clinical practice is now needed.<\/jats:p><\/jats:sec>","DOI":"10.1111\/eci.12857","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:44:36Z","timestamp":1510847076000},"source":"Crossref","is-referenced-by-count":63,"title":["Treatment of <i>Helicobacter pylori<\/i> infection: A clinical practice update"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-8619","authenticated-orcid":false,"given":"Rocco Maurizio","family":"Zagari","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Bologna Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rabitti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Bologna Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Henry","family":"Eusebi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Bologna Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Bazzoli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Bologna Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12165"},{"key":"e_1_2_7_3_1","first-page":"1352","article-title":"Kyoto Global Consensus Report on Helicobacter pylori gastritis","volume":"63","author":"Sugano K","year":"2015","journal-title":"Gut"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05083.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.04.006"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.563"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03807.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0188"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062162"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00006"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200211000-00004"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.782286"},{"key":"e_1_2_7_15_1","first-page":"CD008337","article-title":"Optimum duration of regimens for Helicobacter\u00a0pylori eradication","volume":"12","author":"Yuan Y","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310142"},{"key":"e_1_2_7_17_1","first-page":"CD009034","article-title":"Sequential versus standard triple first\u2010line therapy for\u00a0Helicobacter\u00a0pylori eradication","volume":"6","author":"Nyssen OP","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.04.011"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01169.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11432492"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31409-X"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.t01-1-07288.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60020-2"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12371"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2015.06.010"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13712"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04937.x"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Feci.12857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/eci.12857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:23:58Z","timestamp":1696019038000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/eci.12857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/eci.12857"],"URL":"https:\/\/doi.org\/10.1111\/eci.12857","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"article-number":"e12857"}}